ArticleFrontiers in oncology2025
Impact of personalized nursing on the quality of life in lung cancer patients.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains a leading cause of cancer-related morbidity and mortality worldwide. As systemic therapy prolongs survival, improving patients' quality of life (QoL) has become a central goal of holistic care. Personalized nursing interventions, tailored to individual patient needs, have shown promise in oncology but lack large-scale evaluation in lung cancer populations. Methods: This retrospective cohort study analyzed 291 patients diagnosed with stage II-IV lung cancer who underwent systemic treatment at Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology between January 2022 and December 2024. Patients were categorized into two groups: the intervention group (n = 137), who received personalized nursing care based on individualized symptom assessment, psychological support, and lifestyle counseling; and the control group (n = 154), who received standard nursing care. QoL was assessed using the EORTC QLQ-C30 questionnaire at baseline and at 8 weeks post-intervention. Secondary outcomes included emotional distress (measured by HADS), treatment adherence, and unplanned healthcare utilization. Results: The personalized nursing group demonstrated a significantly greater improvement in overall QoL scores at 8 weeks (mean change: +13.2 ± 7.6 vs. +5.1 ± 6.8, P < 0.001). Notable improvements were also observed in emotional functioning, fatigue, and pain subscales (all P < 0.01). Anxiety and depression scores were significantly reduced in the intervention group (mean HADS total: 12.5 ± 4.1 vs. 16.8 ± 5.3, P < 0.001). Treatment adherence was higher (91.2% vs. 78.6%, P = 0.006), and fewer unplanned clinic visits or emergency admissions were reported (12.4% vs. 23.4%, P = 0.014). Conclusion: Personalized nursing interventions significantly enhance quality of life, emotional well-being, and care adherence in patients with lung cancer. These findings support the integration of individualized nursing strategies into routine oncology practice to optimize both physical and psychological outcomes in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.